CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Net Income Growth by Quarter and Year

Kempharm Inc's Net Income results by quarter and year




KMPH Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -2.70 -4.86 -6.04
III Quarter September -6.62 -1.76 -3.01 3.06
II Quarter June -24.04 6.20 0.86 -9.26
I Quarter March -1.86 -10.30 -5.75 -12.29
FY   -32.52 -8.56 -12.76 -24.53



KMPH Net Income third quarter 2022 Y/Y Growth Comment
Kempharm Inc in the third quarter 2022 recorded net loss of $ -6.62 millions.

According to the results reported in the third quarter 2022, Kempharm Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Kempharm Inc' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




KMPH Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - 620.93 % - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kempharm Inc's third quarter 2022 Net Income $ -6.62 millions KMPH's Income Statement
Kempharm Inc's third quarter 2021 Net Income $ -1.76 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Net Income Growth >>


KMPH Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kempharm Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Net Income Comment
Although Kempharm Inc in the III. Quarter 2022 showed net loss of $ -6.62 millions, it should be mentioned, that those numbers point to recovery compare to the -24.04 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Net Income growth. While Kempharm Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Net Income Comment
Although Kempharm Inc in the III. Quarter 2022 admitted net loss of $ -6.62 millions, it should be said, that current results are improvement in contrast to the -24.04 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Net Income growth. While Kempharm Inc's Net Income growth quarter on quarter, overall rank is .


Kempharm Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -35.23 $ -30.37 $ -0.12 $ -8.56 $ -10.71
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Kempharm Inc' has realized cumulative trailing twelve months net loss of $ -35 millions in the Sep 30 2022 period.
The results are getting worse as the cumulative net loss is becoming larger from $ -30.37 millions in the twelve months ending a quarter before and $ -24.04 millions for the twelve months ending in the quarter a year ago Tuur Janssens mentioned.

Kempharm Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Kempharm Inc' has realized cumulative trailing twelve months net loss of $ -35 millions in the Sep 30 2022 period.
The results are getting worse as the cumulative net loss is becoming larger from $ -30.37 millions in the twelve months ending a quarter before and $ -24.04 millions for the twelve months ending in the quarter a year ago.

Kempharm Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
KMPH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for KMPH's Competitors
Net Income Growth for Kempharm Inc's Suppliers
Net Income Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Ufp Technologies Inc415.70%$ 415.703 millions
Cytek Biosciences Inc 393.06%$ 393.064 millions
The Pennant Group Inc 345.50%$ 345.495 millions
Arctos Northstar Acquisition Corp 328.93%$ 328.926 millions
Vaso Corporation283.72%$ 283.717 millions
Thorne Healthtech Inc 277.24%$ 277.235 millions
Biogen Inc 256.77%$ 256.775 millions
Luna Innovations Inc236.90%$ 236.901 millions
Conmed Corporation208.74%$ 208.737 millions
Chemomab Therapeutics Ltd 172.24%$ 172.237 millions
3m Company168.82%$ 168.824 millions
Pacific Health Care Organization Inc 149.86%$ 149.857 millions
Msa Safety Inc138.57%$ 138.570 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

QLGN's Profile

Stock Price

QLGN's Financials

Business Description

Fundamentals

Charts & Quotes

QLGN's News

Suppliers

QLGN's Competitors

Customers & Markets

Economic Indicators

QLGN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071